Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: docetaxel|DRUG: gefitinib
Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)